{"public_id":"cl_8ad9bf93ad9598c1ddc83ae45fc3f60a","status":"active","superseded_by_public_id":null,"corpus_id":6353210,"text":"Prolonged neutropenia and T-cell immunodeficiency are major risk factors for severe fusariosis, especially in hematopoietic stem cell transplant recipients with severe graft-versus-host disease.","confidence":0.95,"paper":{"corpus_id":6353210,"title":"Fusarium Infections in Immunocompromised Patients","url":"https://sah.borca.ai/papers/6353210"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.95,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_3760eaebd02f9241d18c60cbe1fa1939","name":"T-cell immunodeficiency","description":"A deficiency in T-cell-mediated immune function.","types":["risk factor"],"url":"https://sah.borca.ai/concepts/co_3760eaebd02f9241d18c60cbe1fa1939"},{"public_id":"co_9e805d15f1d69e2585df599fd218de18","name":"prolonged neutropenia","description":"An extended period of abnormally low neutrophil counts.","types":["risk factor"],"url":"https://sah.borca.ai/concepts/co_9e805d15f1d69e2585df599fd218de18"},{"public_id":"co_b4e93faf093fb88a72ad3459f88c4f0d","name":"hematopoietic stem cell transplant recipients with severe graft-versus-host disease","description":"Transplant recipients who develop severe graft-versus-host disease after hematopoietic stem cell transplantation.","types":["patient group"],"url":"https://sah.borca.ai/concepts/co_b4e93faf093fb88a72ad3459f88c4f0d"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_8ad9bf93ad9598c1ddc83ae45fc3f60a"}